Search Within

Stephen Stacy Roberts

Formats
  1. Journal Article (52)
  2. Meeting Abstract (50)
  3. Review (2)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Neuroblastoma Service (107)
  2. Pediatrics, Department of (107)
  3. GSK Faculty (74)
  4. Tow Center for Developmental Oncology (TCDO) (74)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (62)
  6. Center for Hematologic Malignancies (49)

More Groups

People
  1. Shakeel Modak (68)
  2. Ellen Basu (64)
  3. Brian Kushner (63)
  4. Nai-Kong Cheung (61)
  5. Kim Kramer (31)
  6. Audrey Mauguen (18)

More People

Years
  1. 2025 (1)
  2. 2023 (12)
  3. 2022 (7)
  4. 2021 (12)
  5. 2020 (13)
  6. 2019 (19)

More Years

Publications
  1. Pediatric Blood and Cancer (35)
  2. Journal of Clinical Oncology (10)
  3. Cancer Research (6)
  4. Neuro-Oncology (5)
  5. Cancer (4)
  6. International Journal of Cancer (4)

More Publications

Publishers
  1. Wiley Periodicals, Inc (36)
  2. American Society of Clinical Oncology (12)
  3. American Association for Cancer Research (9)
  4. Oxford University Press (6)
  5. Elsevier Inc. (5)
  6. Nature Publishing Group (5)

More Publishers

Results (107)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of on-target adverse events caused by TRK inhibitor therapy
    Journal Article

    Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Extracellular vesicle and particle biomarkers define multiple human cancers
    Journal Article

    Hoshino, A.; Kim, H. S.; Bojmar, L.; Gyan, K. E.; Cioffi, M.; Hernandez, J.; Zambirinis, C. P.; Rodrigues, G.; Molina, H.; Heissel, S.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • COVID-19 disease in New York City pediatric hematology and oncology patients
    Correspondence

    Gampel, B.; Troullioud Lucas, A. G.; Broglie, L.; Gartrell-Corrado, R. D.; Lee, M. T.; Levine, J.; Orjuela-Grimm, M.; Satwani, P.; Glade-Bender, J.; Roberts, S. S.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Chemotherapy induced thrombocytopenia in pediatr solid tumor patients
    Meeting Abstract

    Armstrong, K.; Ortiz, M.; Roberts, S.; Dunkel, I.; Goss, C.; Emily, S.; Soff, G.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • MYCN-amplified neuroblastoma with vasoactive intestinal peptide syndrome and BRAF V600e mutation
    Meeting Abstract

    Shahid, S.; Kushner, B.; Modak, S.; Basu, E.; Rubin, E.; Roberts, S.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures
    Journal Article

    Qadeer, Z. A.; Valle-Garcia, D.; Hasson, D.; Sun, Z.; Cook, A.; Nguyen, C.; Soriano, A.; Ma, A.; Griffiths, L. M.; Zeineldin, M.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save